DC Chemicals

All products / DC20017

(S)-Mapracorat
CAT. NO. DC20017

(S)-Mapracorat

Pack sizes and prices

Pack sizePrice
100 mg$1,200 USDRequest a quote →
250 mg$2,400 USDRequest a quote →
1 g$4,800 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

In Vitro (S)-Mapracorat concentration dependently inhibited TNFα secretion from activated canine PBMC with IC50 value of approximately 0.2 nM. In Vivo Intradermal injection of compound 48/80 (50 μg in 50 μL saline) resulted in a clear wheal and flare reaction over the 60 min observation period. Topical pre-treatment with (S)-Mapracorat (0.1%) and triamcinolone acetonide (0.015%) led to significant reduction in the wheal and flare responses compared to vehicle (acetone) treated areas. However, once daily topical administration of triamcinolone acetonide significantly reduced skin fold thickness from day 8 to 14, whereas no such reduction was observed for (S)-Mapracorat.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC20017
Product name(S)-Mapracorat
CAS887375-15-7
Molecular formulaC25H26F4N2O2
Molecular weight462.48
Purity>98%
SMILESCC1=NC2=C(C=C1)C(=CC=C2)NC[C@@](CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — (S)-Mapracorat (DC20017)

Related research products